(MENAFN- Market Press Release) October 8, 2025 3:21 am - Apelo Consulting has released a report on Global Veterinary Point of Care Diagnostics Market (By Animal, Product, Indication, Sample Type, Testing, End User) and Regional Analysis – Forecast to 2030

The global veterinary point of care diagnostics market was valued at USD 2,761 Million in 2024, and is projected to reach USD 5,010 Million by 2030. Veterinary point of care diagnostics refers to diagnostic tools and technologies that help in the early detection of diseases and on-site testing of health conditions that provide a real-time result, helping the veterinarians and farmers to make treatment decisions for the well-being of the animals. The rising population of both companion and livestock animals contributes to the increased demand for effective diagnostic tools.

The increasing prevalence of zoonotic and transboundary diseases further contributes to the market growth. For example, according to the report published by the NIH, about 60% of all known human infectious diseases are zoonotic, and around 75% of emerging infectious diseases are of animal origin. Also, the increasing prevalence of infectious diseases in companion animals, such as parvovirus, feline leukaemia, and heartworm, increases the demand for diagnostic tools that help in early diagnosis of the disease. Furthermore, there are stricter policies pertaining to the health of animals due to concerns regarding food security globally. These policies have led to the implementation of various animal health and wellness programs aimed at ensuring disease control. Regulatory authorities across the world are imposing strict policies to prevent the outbreak of animal-borne diseases by implementing stricter diagnosis and treatment policies, thus contributing to the overall market growth.

Key Highlights of the Report

. The companion animal segment dominated the global veterinary POC diagnostics market owing to high pet ownership and focus on preventative care.

. The market for livestock animals is gaining traction driven by the need to control disease outbreaks, ensure food security, and manage productivity, especially in developing economies.

. Based on product category, the consumables, reagents & kits segment dominates the market. This segment includes essential items like test strips, reactive chemicals, disposable cartridges, and ready-to-use assay kits for detecting infections, parasitic infestations, organ dysfunctions, and chronic diseases in both segments of animals.

. The market for instruments & devices in the veterinary POC diagnostics is driven by the advances in point-of-care equipment such as benchtop chemistry analyzers, hematology systems, imaging tools, and digital cytology platforms.

. In terms of indication, the infectious disease segment is the largest and most critical area in veterinary POC diagnostics. The rapid POC tests are widely used to detect viral, bacterial, and parasitic infections such as canine parvovirus, feline leukemia (FeLV/FIV), leptospirosis, Lyme disease, and avian influenza.

. The general ailments segment covers routine diagnostic testing for non-infectious, often chronic or metabolic conditions including diabetes, kidney disease, liver disorders, anemia, and electrolyte imbalances.

. The blood/plasma/serum segment held a prominent position in veterinary POC diagnostics. These fluid samples are integral to detecting a wide range of systemic conditions in both companion and livestock animals, such as anaemia, electrolyte imbalance, infectious diseases including parvovirus, Lyme disease, and metabolic disorders like diabetes and kidney dysfunction.

. The demand for fecal samples is particularly significant in puppy and kitten clinics and shelters, and also for farm animals, where parasite burden can have a major effect on animal health.

. The urine sample is widely used for detecting kidney disorders, UTIs, diabetes, and metabolic issues, especially in dogs and cats, where non-invasive sample collection is a major advantage.

. Based on testing category, parasitology segment dominates the global veterinary POC diagnostics market. This segment is primarily focused on the identification of internal and external parasites including giardia, heartworms, roundworms, fleas, and ticks.

. The bacteriology segment is expected to expand steadily by 2030 as concerns over antimicrobial resistance grow and demand for rapid, field-ready diagnostics rises.

. The diagnostic imaging plays a crucial role in detection of musculoskeletal injuries, internal organ health, reproductive status, and tumour localization.

. The virology segment involves the immediate detection of viral pathogens, which are responsible for diseases such as canine parvovirus, feline leukemia (FeLV), feline immunodeficiency virus (FIV), avian influenza, and porcine reproductive and respiratory syndrome (PRRS).

. Veterinary clinics and hospitals represent the largest end-user segment in the global veterinary point-of-care (POC) diagnostics market. As the primary access point for both companion and livestock animals, these facilities rely heavily on rapid diagnostic solutions to support routine screenings, emergency interventions, surgical procedures, and chronic disease management.

. Home care is an emerging segment in the veterinary PoC diagnostics market. As pet ownership and health awareness continue to rise, particularly in urban and semi-urban areas, the home care segment is well-positioned for sustained market growth.

. The North America dominated the global veterinary point of care diagnostics market, driven by the increasing incidence of animal diseases and the growing demand for rapid and on-site diagnostics. The region is experiencing accelerated adoption of advanced diagnostic technologies, including AI-powered imaging systems, mobile-compatible analyzers, and cloud-integrated platforms. These innovations are enhancing diagnostic capabilities across both clinical and on-farm settings.

. Veterinary point-of-care (PoC) diagnostics are gaining significant traction across Europe, emerging as a critical enabler of rapid, on-site disease detection in both companion animals and livestock. The adoption has been strongest in Germany, the United Kingdom, and France, supported by mature veterinary infrastructures and heightened public awareness of zoonotic risks.

. The Asia-Pacific veterinary point-of-care (PoC) diagnostics market is expanding rapidly, driven by a sharp rise in both companion animal care and livestock health management. In developed markets such as Japan, South Korea, and Australia, increasing urban pet ownership is fueling higher spend on preventive healthcare and wellness diagnostics.

For more details, please visit:

MENAFN08102025003520003262ID1110167968